|
|
|
|
|
by semenko
1495 days ago
|
|
The lack of a stockpile is due to limited shelf stability and long-term bacterial growth. It's unfortunate Reason doesn't expand on the other side of this issue: the formula industry lobbied the FDA to reduce bacterial testing frequency (and inspections overall), with an emphasis on Cronobacter risks, arguing that the FDA "overestimat[ed] the expected annual incidence of Cronobacter infection". [1] [1] https://theintercept.com/2022/05/13/baby-formula-shortage-ab... |
|
Four manufacturers, consisting of 89% of the nations supply, have so much influence over a regulatory agency insofar that they can write their own rules. Four manufacturers are able to shape the competitive landscape because the government has deemed their voices vital.